Skip to main content
British Medical Journal logoLink to British Medical Journal
letter
. 1966 Mar 26;1(5490):803. doi: 10.1136/bmj.1.5490.803-a

Hallucinosis on Combined Methyldopa and Pargyline

E S Paykel
PMCID: PMC1844519  PMID: 5910115

Full text

PDF

Page 803

803

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FULLERTON A. G., MORTON-JENKINS D. Methyldopa and depression. Br Med J. 1963 Feb 23;1(5329):538–539. doi: 10.1136/bmj.1.5329.538-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. VAN ROSSUMJ, HURKMANS J. A. REVERSAL OF THE EFFECT OF ALPHA-METHYLDOPA BY MONOAMINE OXIDASE INHIBITORS. J Pharm Pharmacol. 1963 Aug;15:493–499. doi: 10.1111/j.2042-7158.1963.tb12824.x. [DOI] [PubMed] [Google Scholar]
  3. van ROSSUM J. Potential dangers of monoamineoxidase inhibitors and alpha-methyldopa. Lancet. 1963 Apr 27;1(7287):950–951. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES